GE Healthcare Technologies Inc. received U.S. FDA approval for its novel radiotracer, Flyrcado (flurpiridaz F-18), for use in ...

The injectable tracer, Flyrcado, could help doctors flag deadly coronary artery disease in patients during imaging tests.

Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report) and keeping ...

GE HealthCare shares are up nearly 1% after getting the green light late Friday from U.S. regulators to sell a new diagnostic imaging agent that analysts say could be a big seller for the [General Ele ...

Flyrcado is designed for patients with known or suspected CAD, providing a ready-to-use unit dose that can be manufactured ...

The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...

U Mobile partners with ZTE to boost 5G in rural Malaysia, enhancing connectivity and driving digital transformation in ...

The comment section quickly filled with people who disagreed with localandvocal’s characterization of CareCredit as a ...

We recently compiled a list of 10 Best Young Stocks To Buy Now. In this article, we will look at where GE Healthcare ...

Bristol Myers gains FDA approval for a new schizophrenia drug. HHS declares a health emergency in Georgia due to Hurricane ...

This summary of current health news includes FDA approvals for new drugs by Bristol Myers and GE HealthCare, public health ...

Prenatal screening is important for early detection of congenital anomalies, ensuring informed decisions for expectant ...